Mesenchymal Stem Cells and Inflammatory Cardiomyopathy: Cardiac Homing and Beyond
Open Access
- 1 January 2011
- journal article
- Published by Hindawi Limited in Cardiology Research and Practice
- Vol. 2011, 1-8
- https://doi.org/10.4061/2011/757154
Abstract
Under conventional heart failure therapy, inflammatory cardiomyopathy usually has a progressive course, merging for alternative interventional strategies. There is accumulating support for the application of cellular transplantation as a strategy to improve myocardial function. Mesenchymal stem cells (MSCs) have the advantage over other stem cells that they possess immunomodulatory features, making them attractive candidates for the treatment of inflammatory cardiomyopathy. Studies in experimental models of inflammatory cardiomyopathy have consistently demonstrated the potential of MSCs to reduce cardiac injury and to improve cardiac function. This paper gives an overview about how inflammation triggers the functionality of MSCs and how it induces cardiac homing. Finally, the potential of intravenous application of MSCs by inflammatory cardiomyopathy is discussed.Keywords
Funding Information
- Bundesministerium für Bildung und Forschung
This publication has 72 references indexed in Scilit:
- Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditisEuropean Heart Journal, 2010
- Angiotensin-Converting Enzyme Inhibition Prevents the Release of Monocytes From Their Splenic Reservoir in Mice With Myocardial InfarctionCirculation Research, 2010
- Genetic Modification of Mesenchymal Stem Cells Overexpressing CCR1 Increases Cell Viability, Migration, Engraftment, and Capillary Density in the Injured MyocardiumCirculation Research, 2010
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial InfarctionJournal of the American College of Cardiology, 2009
- Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacityProceedings of the National Academy of Sciences of the United States of America, 2009
- Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory SitesScience, 2009
- Influence of Adult Mesenchymal Stem Cells onIn VitroVascular FormationTissue Engineering, Part A, 2009
- Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardiumJournal of Molecular and Cellular Cardiology, 2008
- Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for HomingThe International Journal of Cell Cloning, 2007
- The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cellsBiochemical and Biophysical Research Communications, 2007